Cargando…

Lipopolysaccharide‐induced hypothalamic inflammation in cancer cachexia‐anorexia is amplified by tumour‐derived prostaglandin E2

BACKGROUND: Cachexia‐anorexia syndrome is a complex metabolic condition characterized by skeletal muscle wasting, reduced food intake and prominent involvement of systemic and central inflammation. Here, the gut barrier function was investigated in pancreatic cancer‐induced cachexia mouse models by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaolin, Holtrop, Tosca, Jansen, Fleur A.C., Olson, Brennan, Levasseur, Pete, Zhu, Xinxia, Poland, Mieke, Schalwijk, Winni, Witkamp, Renger F., Marks, Daniel L., van Norren, Klaske
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745464/ https://www.ncbi.nlm.nih.gov/pubmed/36303458 http://dx.doi.org/10.1002/jcsm.13093

Ejemplares similares

Increased hypothalamic serotonin turnover in inflammation-induced anorexia
por: Dwarkasing, J. T., et al.
Publicado: (2016)

Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
por: Vinke, Paulien, et al.
Publicado: (2021)

Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
por: Vinke, Paulien, et al.
Publicado: (2018)

Hypothalamic food intake regulation in a cancer-cachectic mouse model
por: Dwarkasing, Jvalini T., et al.
Publicado: (2013)

A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice
por: Plas, Rogier L.C., et al.
Publicado: (2019)

Anti-inflammatory nutrition with high protein attenuates cardiac and skeletal muscle alterations in a pulmonary arterial hypertension model
por: Vinke, Paulien, et al.
Publicado: (2019)

Anorexia–cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma
por: Balcázar-Hernández, Lourdes, et al.
Publicado: (2017)

Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling
por: Dwarkasing, Jvalini T, et al.
Publicado: (2015)

Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006)

Leptin in Anorexia and Cachexia Syndrome
por: Engineer, Diana R., et al.
Publicado: (2012)

Cachexia-anorexia in cancer patients
Publicado: (1996)

Endurance Exercise Increases Intestinal Uptake of the Peanut Allergen Ara h 6 after Peanut Consumption in Humans
por: JanssenDuijghuijsen, Lonneke M., et al.
Publicado: (2017)

Pathophysiology of anorexia in the cancer cachexia syndrome
por: Ezeoke, Chukwuemeka Charles, et al.
Publicado: (2015)

Salivary concentrations of secretory leukocyte protease inhibitor and matrix metallopeptidase-9 following a single bout of exercise are associated with intensity and hydration status
por: Knipping, Karen, et al.
Publicado: (2023)

Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010)

Hypothalamic tumour presenting as anorexia nervosa.
por: McClean, P., et al.
Publicado: (1988)

Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia
por: Olson, Brennan, et al.
Publicado: (2021)

Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice
por: van Norren, Klaske, et al.
Publicado: (2015)

Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
por: Gionfriddo, Giulia, et al.
Publicado: (2020)

Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome
por: Fujitsuka, Naoki, et al.
Publicado: (2014)

Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018)

Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC
por: Blauwhoff-Buskermolen, Susanne, et al.
Publicado: (2017)

Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
por: Peixoto da Silva, Sara, et al.
Publicado: (2020)

Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis
por: Archid, Rami, et al.
Publicado: (2019)

Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
por: Yeom, Eunbyul, et al.
Publicado: (2022)

Establishment and characterization of a novel murine model of pancreatic cancer cachexia
por: Michaelis, Katherine A., et al.
Publicado: (2017)

Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
por: Fujitsuka, N, et al.
Publicado: (2011)

Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
por: Mantovani, Giovanni, et al.
Publicado: (2013)

Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia
por: Morley, John E.
Publicado: (2017)

The effect of endurance exercise on intestinal integrity in well‐trained healthy men
por: JanssenDuijghuijsen, Lonneke M., et al.
Publicado: (2016)

Kinetics of Physiological Responses as a Measure of Intensity and Hydration Status During Experimental Physical Stress in Human Volunteers
por: Kartaram, Shirley W., et al.
Publicado: (2020)

Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
por: Brierley, Daniel I., et al.
Publicado: (2019)

Pharmacological studies of the involvement of hypothalamic prostaglandins in the regulation of thyrotropin secretion.
por: Wright, K C, et al.
Publicado: (1981)

Microglia in the hypothalamus respond to tumor‐derived factors and are protective against cachexia during pancreatic cancer
por: Burfeind, Kevin G., et al.
Publicado: (2020)

Effects of whole-body vibration training in a cachectic C26 mouse model
por: van der Ende, Miranda, et al.
Publicado: (2021)

Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia
por: Ihnatko, R, et al.
Publicado: (2013)

Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin
por: Anker, Stefan D, et al.
Publicado: (2015)

Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome [Retraction]
Publicado: (2013)

The Pathophysiology of Anorexia Nervosa in Hypothalamic Endocrine Function and Bone Metabolism
por: Jada, Keji, et al.
Publicado: (2021)

Hypothalamic BOLD response to glucose intake and hypothalamic volume are similar in anorexia nervosa and healthy control subjects
por: van Opstal, Anna M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h3vlkl276sihl28eshl8ipfasn